Overexpression of PCSK9 in mice leads to decreased hepatic LDL-R levels and elevated serum cholesterol, while PCSK9 gene inactivation slows atherosclerosis progression [30,31]. This evidence concerns the gene PCSK9 and atherosclerosis.